Ignite Creation Date:
2025-12-26 @ 5:20 PM
Ignite Modification Date:
2026-03-03 @ 11:55 PM
Study NCT ID:
NCT00598806
Status:
COMPLETED
Last Update Posted:
2017-11-13
First Post:
2008-01-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)
Sponsor:
Spectrum Pharmaceuticals, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-08
Start Date Type:
ACTUAL
Primary Completion Date:
2012-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-11
First Submit QC Date:
None
Study First Post Date:
2008-01-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-07-14
Results First Submit QC Date:
None
Results First Post Date:
2017-08-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-06-19
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-10-10
Last Update Post Date:
2017-11-13
Last Update Post Date Type:
ACTUAL